Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Even 53 Cents Is Too Much for Zomedica Stock Right Now ↗
At one point, investors loved Zomedica. But until its plans come to fruition, ZOM stock doesn't look like much of a deal. 
Via InvestorPlace
News headline image
If at First Zomedica Doesn’t Succeed, It Tries, Tries Again ↗
The launch of the Truforma diagnostic platform didn't go perfectly for Zomedica, but holders of ZOM stock still have reason for optimism. 
Via InvestorPlace
News headline image
Is Zomedica Stock Worth the Risk? Unfortunately It’s Complicated ↗
Zomedica started selling its TRUFORMA vet diagnostic system in March, but ZOM stock won’t see upside until supplier assay issues are resolved. 
Via InvestorPlace
Topics Supply Chain
News headline image
Why Economic Pressure May Build Against Zomedica ↗
Although ZOM stock banks superficially on millennials’ love for pets, brewing economic pressures may undo this catalyst. 
Via InvestorPlace
News headline image
Zomedica Continues to Execute Poorly ↗
It's been 3.5 months since Zomedica launched Truforma. Unfortunately, due to its poor execution, ZOM stock continues to suffer. 
Via InvestorPlace
News headline image
Zomedica’s Business Model Is Good, But It’s Still Overpriced ↗
Giving away razors and charging for the blades is often a good idea, but ZOM stock still isn't a good value until it drops closer to 40 cents. 
Via InvestorPlace
News headline image
The Time to Buy Zomedica Stock May Be Near ↗
After its post-meme collapse, pet healthcare play ZOM stock is still pricey. Wait for it to inch closer to a more optimal entry point. 
Via InvestorPlace
News headline image
Zomedica Needs to Start Delivering Tangible Results ↗
Zomedica has an interesting story that could work out. However, the company's inability to execute is raising key concerns about ZOM stock. 
Via InvestorPlace
News headline image
Risks Outweigh Rewards of a Move Into Zomedica Stock Right Now ↗
ZOM stock needs to ramp up sales by a significant margin before investors can get excited about investing in it at this time 
Via InvestorPlace
News headline image
ZOM Stock Is on the Move, but That Doesn’t Make It a Good Play Here ↗
After months of declining, ZOM stock may have found a floor. The question is if that will hold. Set this one aside for the time being. 
Via InvestorPlace
News headline image
63 Biggest Movers From Yesterday ↗
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11... 
Via Benzinga
News headline image
Zomedica's Stock Approaches Important Level ↗
Shares of Zomedica Corp. (NYSE: ZOM) are trading higher after the company released earnings. If the stock continues to rally, there's a chance it runs into sellers around... 
Via Benzinga
News headline image
45 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,... 
Via Benzinga
News headline image
Why Zomedica Stock Is Zooming Higher Today ↗
Investors appear to be bullish about the stock after a major investment bank disclosed earlier this week that it had bought shares of Zomedica. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ZOM Stock: What Investors Are Saying About Meme Stock Favorite Zomedica as Shares Fly ↗
Zomedica (ZOM) stock is soaring higher on Thursday as the stock continues a rally that's been taking place over the last couple of days. 
Via InvestorPlace
News headline image
22 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Good Works Acquisition Corp. (NASDAQ: GWAC) rose 29.8% to $13.01 in pre-market trading. Good Works Acquisition and Cipher Mining reported shareholder approval of business... 
Via Benzinga
News headline image
1 Number That Might Send Investors Running From Zomedica's Stock ↗
A lack of sales growth and rising expenses could send this struggling stock even lower. 
Via The Motley Fool
News headline image
ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1? ↗
Today, investors in Zomedica are seeing a lot of green as a recent meme-stock surge takes ZOM stock materially higher. 
Via InvestorPlace
News headline image
The Second Half of 2021 Should Be Much Easier for Zomedica Investors ↗
So far, it hasn't been easy to stay the course with ZOM stock. Q3 and Q4 developments, however, should lift the shareholders' spirits. 
Via InvestorPlace
News headline image
Why Zomedica Stock Has Lost Its Luster ↗
There are a few glaring reasons behind the once high-flying stock's decline. 
Via The Motley Fool
News headline image
77 Biggest Movers From Yesterday ↗
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
News headline image
54 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency... 
Via Benzinga
News headline image
What's Happening With Zomedica's Stock Today? ↗
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 13.6% at $0.49 Thursday morning after the company reported second-quarter earnings results. Zomedica reported... 
Via Benzinga
News headline image
30 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Conifer Holdings, Inc. (NASDAQ: CNFR) shares rose 40.9% to $4.00 in pre-market trading after the company reported better-than-expected Q2 sales. The ExOne Company (NASDAQ... 
Via Benzinga
News headline image
Zomedica Is an Excellent Spec Play After Falling ↗
ZOM stock is trading at a discount, which means this is the perfect time for investors to trade this one for short-term profits. 
Via InvestorPlace
News headline image
Time Is Passing Too Slowly For Zomedica Speculators ↗
Zomedica speculators are being told to be patient, but there's a time cost to money and some will likely let ZOM stock go soon. 
Via InvestorPlace
News headline image
There’s Little That’s Attractive About Once-Hot Zomedica Stock… for Now ↗
Zomedica has become a slow-motion train wreck. ZOM stock investors should look for alternatives to the animal diagnostics firm. 
Via InvestorPlace
News headline image
Zomedica Stock Might Not Appeal To Millennials as Much as Some Hope ↗
While young people own pets, the question for ZOM stock is whether they will truly care for them. 
Via InvestorPlace
News headline image
Avoid Zomedica Stock As It’s Bogged Down By Too Many Red Flags ↗
Resignation of Zomedica's President and CMO, and the CEO are red flags. Wait to buy ZOM stock until 30 cents for a margin of safety. 
Via InvestorPlace
News headline image
Zomedica Is Still Working Out How to Sell Truforma. Can Investors Afford to Wait? ↗
Zomedica came public too soon, but it does have enough cash to see a finish line. The question is, can ZOM stock investors afford to wait? 
Via InvestorPlace
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.